Fonte: Journal of thoracic oncology. Nome do evento: World Conference on Lung Cancer. Unidade: FM
Assuntos: NEOPLASIAS PULMONARES, POLIMORFISMO, ADENOCARCINOMA, TÉCNICAS CITOLÓGICAS (TENDÊNCIAS)
ABNT
CASTRO JR., Gilberto et al. Polymorphisms in the exon 20 of EGFR gene in metastatic lung adenocarcinoma: prognostic relevance and sensitivity to erlotinib. Journal of thoracic oncology. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 04 out. 2024. , 2013APA
Castro Jr., G., Soares, I. C., Takahashi, T. K., Maia, M. C. D. F., Caires-Lima, R., Protasio, B. M., et al. (2013). Polymorphisms in the exon 20 of EGFR gene in metastatic lung adenocarcinoma: prognostic relevance and sensitivity to erlotinib. Journal of thoracic oncology. Faculdade de Medicina, Universidade de São Paulo.NLM
Castro Jr. G, Soares IC, Takahashi TK, Maia MCDF, Caires-Lima R, Protasio BM, Takagaki TY, Shiang C, Mello ES, Hoff PM, Alves VA. Polymorphisms in the exon 20 of EGFR gene in metastatic lung adenocarcinoma: prognostic relevance and sensitivity to erlotinib. Journal of thoracic oncology. 2013 ; 8 S784.[citado 2024 out. 04 ]Vancouver
Castro Jr. G, Soares IC, Takahashi TK, Maia MCDF, Caires-Lima R, Protasio BM, Takagaki TY, Shiang C, Mello ES, Hoff PM, Alves VA. Polymorphisms in the exon 20 of EGFR gene in metastatic lung adenocarcinoma: prognostic relevance and sensitivity to erlotinib. Journal of thoracic oncology. 2013 ; 8 S784.[citado 2024 out. 04 ]